A Phase I Trial of Berberine in Chinese with Ulcerative Colitis
Li Xu(Northwestern University), Kaichun Wu(Moderna Therapeutics (United States)), Guang‐Yu Yang(Northwestern University), Sijung Hu(Xijing Hospital), Asad Umar(Center for Cancer Research), Aidong Wen(Xijing Hospital), Luz M. Rodriguez(Walter Reed National Military Medical Center), Kelly A. Benante(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Raymond C. Bergan(Northwestern University), Ellen Richmond(Georgetown University), Seema A. Khan(Northwestern University), Yujie Zhang(Xijing Hospital), Jie Liu(Fudan University), Yueyun Ma(United States Air Force), Yan Pan(Xijing Hospital), Ying Song(Zoucheng People's Hospital), Borko Jovanovic(Northwestern University), Xianmin Xue(Xijing Hospital), Zeng-Shan Li(Xijing Hospital), Mary Beth Tull(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Yanyan Jia(Ministry of Education of the People's Republic of China), Ying Cao(Xijing Hospital)
Cited by 73
Related Papers
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|480